Home » Topics » Regulatory

Regulatory
RSS

Esmya approved in Europe

Feb. 27, 2012

European Commission approves Glivec label update

Feb. 27, 2012

FDA grants first approval for drug-eluting coronary stent use in AMI

Feb. 23, 2012

BMS gains additional indication approvals for two anticancer drugs

Feb. 23, 2012

Line extension for Zyprexa approved in Japan

Feb. 23, 2012

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

FDA approves first medical therapy for endogenous Cushing's syndrome

Feb. 20, 2012

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

FDA approves new gel for male hypogonadism

Feb. 16, 2012

Line extension for Vyvanse in U.S.

Feb. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...